Page last updated: 2024-10-26

pentetic acid and Alloxan Diabetes

pentetic acid has been researched along with Alloxan Diabetes in 8 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Research Excerpts

ExcerptRelevanceReference
"Alloxan diabetes may be mediated by an iron-catalyzed formation of hydroxyl radicals."3.66Opposite effects of two metal-chelators on alloxan-induced diabetes in mice. ( Grankvist, K; Marklund, SL, 1983)
" The relative oral bioavailability of insulin was approximately 20%."1.38Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. ( Chuang, EY; Ho, YC; Lin, KJ; Maiti, B; Panda, N; Sonaje, K; Su, FY; Sung, HW; Wey, SP; Yen, TC, 2012)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, EY3
Lin, KJ3
Lin, PY2
Chen, HL2
Wey, SP2
Mi, FL2
Hsiao, HC1
Chen, CT1
Sung, HW3
Chiu, YH1
Juang, JH1
Chiang, CH1
Su, FY1
Sonaje, K1
Yen, TC1
Ho, YC1
Panda, N1
Maiti, B1
Hutchings, SR1
Song, D1
Fricker, SP1
Pang, CC1
Medarova, Z1
Castillo, G1
Dai, G1
Bolotin, E1
Bogdanov, A1
Moore, A1
Grankvist, K1
Marklund, SL1
Heikkila, RE1
Cabbat, FS1
Tervahartiala, P1
Kivisaari, L1
Kivisaari, R1
Virtanen, I1

Other Studies

8 other studies available for pentetic acid and Alloxan Diabetes

ArticleYear
Self-assembling bubble carriers for oral protein delivery.
    Biomaterials, 2015, Volume: 64

    Topics: Administration, Oral; Animals; Capsules; Cell Line, Tumor; Diabetes Mellitus, Experimental; Drug Car

2015
Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 08-10, Volume: 259

    Topics: Administration, Oral; Animals; Blood Glucose; Caco-2 Cells; Diabetes Mellitus, Experimental; Drug Ca

2017
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Biomaterials, 2012, Volume: 33, Issue:9

    Topics: Absorption; Administration, Oral; Animals; Biological Availability; Blood Glucose; Cell Adhesion; Ch

2012
The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes.
    European journal of pharmacology, 2005, Dec-28, Volume: 528, Issue:1-3

    Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Synergism; Fr

2005
Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes.
    Diabetes, 2007, Volume: 56, Issue:11

    Topics: Angiography; Animals; Blood Glucose; Contrast Media; Diabetes Mellitus, Experimental; Female; Gadoli

2007
Opposite effects of two metal-chelators on alloxan-induced diabetes in mice.
    Life sciences, 1983, Dec-19, Volume: 33, Issue:25

    Topics: Alloxan; Animals; Blood Glucose; Deferoxamine; Diabetes Mellitus, Experimental; Hydrogen Peroxide; M

1983
The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: suggestion of a role for iron in the cytotoxic process.
    Experientia, 1982, Mar-15, Volume: 38, Issue:3

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Edetic Acid; Male; Mice; Pentetic Acid

1982
Contrast media-induced renal morphologic lesions in diabetic rats.
    Acta radiologica (Stockholm, Sweden : 1987), 1993, Volume: 34, Issue:3

    Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Diatrizoate; Female; Gadolinium DTPA; Iohe

1993